Intravenous Fluid Therapy Is Associated with a Reduced Incidence of Contrast-Induced Nephropathy but not with a Reduced Long-Term Incidence of Renal Dysfunction After Cardiac Catheterization
Highlights
- • Intravenous fluid therapy is recommended for the prevention of contrast-induced nephropathy, especially in patients at risk.
- • We investigated the association between intravenous fluids and contrast-induced nephropathy and nephropathy at 3 months.
- • We found that intravenous fluid therapy was associated with a decreased incidence of contrast-induced nephropathy.
- • However, intravenous fluid therapy was not associated with a decreased incidence of nephropathy at 3 months.
Abstract
Background
Intravenous fluid (IVF) administration for the prevention of contrast-induced nephropathy (CIN) is considered standard of care, but the effect of IVF therapy on longer-term outcomes after radiocontrast dye administration is not well known.